𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of micronutrients and alternative drugs by children with acute lymphoblastic leukemia

✍ Scribed by Möttönen, Merja; Uhari, Matti


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
38 KB
Volume
28
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


The use of alternative therapies is thought to be common among cancer patients. To clarify the popularity of micronutrients among children with cancer, we performed a controlled follow-up survey. The use of micronutrients and alternative drugs by 15 families of children with acute lymphoblastic leukemia (ALL) receiving chemotherapy (62 members) and 26 control families (106 members) was monitored by means of daily diaries from November 1987 to December 1989. Forty percent of children with ALL (6 of 15) and 7.7% of their controls (2 of 26) took alternative medicines, the usage among the children with ALL being statistically significantly more common (difference, 32.3%; 95% confidence interval for difference [CI] 7.1, 57.5%; P < 0.04). All children with ALL and 50.0% of the control children (13 of 26) took vitamins (difference, 50.0%; 95% CI, 20.4-79.6%; P < 0.01). A total of 27.7% of the other members of the ALL families (13 of 47) and 11.1% of their counterparts in the control families (10 of 90) took alternative medicines, the usage in the index families being statistically significantly more common (difference, 16.6%; 95% CI, 3.4-29.7%; P < 0.03). The malignancy increased the use of alternative medicines among all members of the family and of vitamins and trace elements among the affected children.


📜 SIMILAR VOLUMES


Alternating drug pairs with or without p
✍ George R. Buchanan; Gaston K. Rivera; Brad H. Pollock; James M. Boyett; Allen R. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Background: Children with acute lymphoblastic leukemia (all) who experience hematologic recurrence while receiving chemotherapy or within 6 months after its cessation have a low cure rate. in this study (pediatric oncology group protocol 8303) two methods were examined for improving the outcome

The use of higher dose clofarabine in ad
✍ Bradley A. McGregor; Alexander W. Brown; Michael B. Osswald; Michael R. Savona 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## Abstract The standard dose of clofarabine is 52 mg/m^2^ for pediatrics and 40 mg/m^2^ in adults. Clofarabine dosed at 52 mg/m^2^ was used in adult patients with refractory ALL to maximize response before allo‐HSCT. All patients had a significant response to therapy. Published pharmacokinetic ana

Outcomes and prognostic factors of Chine
✍ Shing, Matthew Ming Kong; Li, Chi Kong; Chik, Ki Wai; Lam, Tai Kwan; Lai, Howard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

## Background: The chinese population is the biggest ethnic group in the world. however, there are few reports on the treatment outcome of childhood acute lymphoblastic leukaemia (all) among the chinese population. ## Procedure: Sixty-five children with all were treated with a modified protocol o